
Sign up to save your podcasts
Or


This week, we’re saying goodbye to doom and gloom by bringing you a few juicy titbits to brighten up your Monday. First of all – Birkenstocks. Everyone’s favourite sandal is going public! After keeping things private for 250 years, this German institution is ready to IPO and the world is pretty excited. Whether you’re into a classic slide, an oiled leather sandal or a sock-and-clog combo, this is one IPO to watch. And it’s not all about hoofs – we’re also talking big changes for Disney, good news for UK inflation rates, a great week for Klaviyo’s 37-year-old multi-billionaire founder, and (on a less positive note) the outcome of the Kevin Costner prenup-battle.
For more from The Curve:
Instagram
Website
TikTok
Newsletter
Disclaimer: Raising The Curve has been prepared solely for informational and educational purposes. Any information provided and serviced described in this website are intended to be of general nature and provide general information only. The opinions expressed by The Curve do not constitute investment advice.
By The Curve Platform4.5
88 ratings
This week, we’re saying goodbye to doom and gloom by bringing you a few juicy titbits to brighten up your Monday. First of all – Birkenstocks. Everyone’s favourite sandal is going public! After keeping things private for 250 years, this German institution is ready to IPO and the world is pretty excited. Whether you’re into a classic slide, an oiled leather sandal or a sock-and-clog combo, this is one IPO to watch. And it’s not all about hoofs – we’re also talking big changes for Disney, good news for UK inflation rates, a great week for Klaviyo’s 37-year-old multi-billionaire founder, and (on a less positive note) the outcome of the Kevin Costner prenup-battle.
For more from The Curve:
Instagram
Website
TikTok
Newsletter
Disclaimer: Raising The Curve has been prepared solely for informational and educational purposes. Any information provided and serviced described in this website are intended to be of general nature and provide general information only. The opinions expressed by The Curve do not constitute investment advice.

169 Listeners

146 Listeners

21 Listeners

113 Listeners

19 Listeners

15 Listeners

29 Listeners

294 Listeners

15 Listeners

315 Listeners

58 Listeners

14 Listeners

18 Listeners

3 Listeners

13 Listeners